ArticleNature medicine2024

Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease.

Kilian Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.